Deans Lecture Series 2009
Medical inventors, innovators and entrepreneurs - challenges in a global market
This event, held on the
31st August at the John Niland Scientia Building, was hailed as the most
successful lecture so far with approximately
300 guests in attendance. It was a state-of-the art presentation on medical entrepreneurship in an increasingly dynamic environment. The interactive debate, led by three of Australia’s prominent medical entrepreneurs, considered what it takes to be successful in a global context.
View the Lecture on UNSWTV
Facilitator
Tim Harcourt - Chief Economist of the Australian Trade Commission (Austrade)
Tim Harcourt is the chief economist of the Australian Trade Commission (Austrade). A prolific author and globetrotter, Tim has visited over 45 countries in the past 4 years alone.
Tim is also an active commentator in the Australian and international media on economic issues. Tim appears regularly on TV and Radio shows such as Business Lateline, Lateline, Business Today, Sunrise, Bloomberg, CCTV and CNBC Asia. Tim also writes for a number of newspapers, magazines, websites and blogs.
Before joining the Austrade, Tim worked for the ACTU, the RBA and in the private sector in the UK, the USA and Israel.
Tim was educated at the University of Adelaide, the University of Minnesota and Harvard University. He is also the author of the current best-seller, "The Airport Economist".
Speakers
Dr Paul Kelly -
General Partner and Executive Director at OneVentures
“The Road Less Travelled - The physician as entrepreneur: the opportunities and the challenges”
Dr Paul J. Kelly, MBBS, MD, FRACP is a Boston based Australian physician, entrepreneur and biotechnology and lifesciences executive with over 15 years experience in commercialising lifescience related technologies in Australia, Europe and North America.
Dr Kelly is General Partner and Executive Director at OneVentures, an Australian venture capital firm focusing on investing in the Clean Technology and Life Science sectors.
He has enjoyed a distinguished career as a biotechnology executive, co-founding a number of companies in the health sciences and technology arena and is a published and respected physician specialising in endocrinology. Dr Kelly has served on national governmental advisory bodies, as well as on the boards of public and private companies.
Dr Kelly is a graduate of the University of New South Wales where he received his Bachelor of Medicine, Bachelor of Surgery (Honours) and Doctor of Medicine degrees. He is a Fellow of the Australasian College of Physicians.
Dr Kelly's deep knowledge of the field of medicine, established track record as a physician, entrepreneur and leader together with his passion for technology-based healthcare solutions, will see him provide invaluable insights into our topic area.
Dr Chris Roberts - CEO of Cochlear Limited
“Cochlear Implants: Along a multi-disciplinary Journey”
Dr Chris Roberts, is CEO of Cochlear Limited, an iconic Australian company responsible for ground breaking innovations changing the face of healthcare. Dr Roberts has been Director of ResMed Inc since 1992 and is Chairman of Research Australia. With over 33 years experience in the medical device industry and demonstrated exceptional vision and leadership in a global business environment, Dr Roberts is ideally placed to share his insights into medical inventors, innovations and entrepreneurship.
Dr Roberts holds a BE in Chemical Engineering (Honours) (UNSW), an MBA (Macq), and a PhD (UNSW). He is a Fellow of the Academy of Technological Sciences and Engineering (FTSE) and the Australian Institute of Company Directors (FAICD). Dr Roberts holds a place on the UNSW Faculty of Medicine Advisory Council.
Professor Philip Hogg - Director of UNSW Cancer Research Centre
“My journey from the bench to the bedside with a new type of cancer drug”
Professor Philip Hogg, is the Director of UNSW Cancer Research Centre, Head of the CCIA Drug Discovery Program and NH&MRC Senior Principal Research Fellow. Professor Hogg was awarded this year’s prestigious Cancer Institute NSW Premier's Award for Outstanding Cancer Researcher, the highest cancer research honour in NSW. The award acknowledges the potential for Professor Hogg’s research to change cancer treatment and improve the survival chances of patients. Professor Hogg is developing a new frontier of research and is working to commercialise his discoveries to ensure they have major clinical applications.
His work represents a new paradigm in biology and has been recognised by other awards including the Commonwealth Health Minister's Award for Excellence in Health and Medical Research and the GlaxoSmithKline Australia Award for Research Excellence. Professor Hogg has published over 100 research articles and is an inventor on 24 patents.